Cytochrome P450 inhibitor, Abiraterone acetate, Purity ≥98%

Cat. No.: X24-08-YM384

Cytochrome P450 inhibitor, Abiraterone acetate, Purity ≥98%

Synonym: 154229-18-2; CB-7630; Zytiga; [(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

  • MDL: MFCD00934213
  • CAS Number: 154229-18-2
  • Compound CID: 9821849
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Abiraterone acetate, soluble in DMSO and ethanol and insoluble in water, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450. It targets the CYP17 (cell-free assay).
Molecular Weight
391.3
Molecular Formula
C26H33NO2
Targets
CYP17 (Cell-free assay): 72 nM
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: insoluble; Water: insoluble; Ethanol: 27 mg/mL; In vivo: 5% DMSO + 95% Corn oil, 28 mg/mL
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Abiraterone acetate is a metabolism inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of prostate cancer.
Storage
Store at -20ºC, and keep desiccated.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0